Pfizer to pay $325 million in Neurontin settlement
date:Jun 03, 2014
inal charges for illegally marketing Neurontin for unapproved uses such as migraine headaches and pain.

Pfizer obtained Neurontin when it bought Warner-Lambert in 2000.

The case is: In re Neurontin Marketing, Sales Practices, and Products Liability Litigation, U.S. District Court, District of Massachusetts, Nos. MDL 1629, 04-10981.
4/4 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
06/01 22:54